藥明康德欲在波士頓和舊金山設立新的辦事處

　　2014年12月15日，藥明康德宣布將在2015年初于波士頓和舊金山設立兩家新的辦事處。新的辦事處將使公司不管是作為客戶還是投資方，都能夠更便利地接觸位于世界上兩個領先生物科技中心的創新公司。早在10月份，藥明康德就宣布在以色列設立辦事處以拓展那里的生物科技業務。公司現在已經在美國的圣保羅、費城、亞特蘭大、普萊恩斯伯勒（新澤西）和圣迭戈擁有機構。

　　 藥明康德董事長兼CEO李革博士說：“我們的目標是讓任何人、任何公司能夠發明和開發醫療設備來造福全世界的患者，這些新的辦事處使我們的綜合研發平臺更貼近于那兒的企業家和前沿科技。

WuXi Opening Offices in Boston and San Francisco

　　SHANGHAI, Dec. 15, 2014 /PRNewswire/  --WuXi PharmaTech (Cayman) Inc. (WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced that it will open offices in Boston and San Francisco in early 2015. These new offices will give the company greater access to innovative companies in the world's two leading biotech hubs, both as customers and as investments.

　　 In October, WuXi announced that it had opened an office in Israel to tap into the biotech community there.

　　In addition, the company has U.S. facilities in St. Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego.

　　"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.

　　 "These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where is being done."